| D01254 | |
| D number | D01254 |
| Classification | Drug |
| Name | Tofisopam (JP17/INN); Emandaxin (TN) |
| Component | - |
| Formula | C22H26N2O4 |
| Exact mass | 382.1893 |
| Mol weight | 382.4528 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Neuropsychiatric agent DG01567 GABA-A receptor agonist DG01914 Anxiolytics, benzodiazepine derivatives Cyp substrate DG01633 CYP3A substrate Cyp inhibitor DG01522 CYP3A4 inhibitor |
| Remark | Therapeutic category: 1124 ATC code: N05BA23 Chemical group: DG02391 |
| Activity | - |
| Disease | - |
| Comment | Benzodiazepine derivative |
| Target | GABRA/GABRB/GABRD/GABRE/GABRG/GABRP/GABRQ [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192] |
| Metabolism | - |
| Interaction | |
| Other DBs | CAS: 22345-47-7 PubChem: 7848317 ChEBI: 32241 ChEMBL: CHEMBL404216 LigandBox: D01254 NIKKAJI: J11.504E |
| KCF data | - |